The importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial

Sadeleştirilmiş öğe sayfası
dc.contributor.authorOzmen, V.
dc.contributor.authorOzbas, S.
dc.contributor.authorKaranlik, H.
dc.contributor.authorMuslumanoglu, M.
dc.contributor.authorIgci, A.
dc.contributor.authorCanturk, Z.
dc.contributor.authorUtkan, Z.
dc.contributor.authorOzaslan, C.
dc.contributor.authorEvrensel, T.
dc.contributor.authorUras, C.
dc.contributor.authorAksaz, E.
dc.contributor.authorSoyder, A.
dc.contributor.authorUgurlu, U. M.
dc.contributor.authorCol, C.
dc.contributor.authorCabioglu, N.
dc.contributor.authorBozkurt, B.
dc.contributor.authorUzunkoy, A.
dc.contributor.authorSezgin, E.
dc.contributor.authorGurleyik, G.
dc.contributor.authorSoran, A.
dc.date.accessioned2025-10-16T15:22:42Z
dc.date.issued2019
dc.description.abstract44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, SEP 27-OCT 01, 2019
dc.identifier.otherWOS:000491295501127
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7873
dc.publisherOXFORD UNIV PRESS
dc.sourceANNALS OF ONCOLOGY
dc.titleThe importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS